Russia’s Chumakov Federal Scientific Center for the Research and Development of Immune and Biological Products of the Russian Academy of Sciences hopes to receive a license for the use of its CoviVac coronavirus vaccine in children in 2022, …
The Belarusian Health Ministry has greenlighted the import and use of Russia’s CoviVac coronavirus shot, the agency said in a statement on Thursday. "The Belarusian Health Ministry has authorized the import and use of the …
The Chumakov Federal Scientific Center for Research has set a target for October to launch the clinical trials of its CoviVac coronavirus vaccine for the 60+ age group, the center’s Director General Aidar Ishmukhametov told TASS on …
Russia on Saturday approved a third coronavirus vaccine for domestic use, Russian Prime Minister Mikhail Mishustin said on state TV. The vaccine, dubbed CoviVac, has been developed by the Chumakov Scientific Center in Moscow. …
